This commentary on a recently published article from the JAMA Network places in context findings on risks of malfunction in cardiovascular implantable electronic devices during radiation therapy for cancer.
This autopsy study of all incident sudden cardiac deaths in San Francisco determines causes of death in individuals with cardiac implantable electronic devices over 35 months.
Zusterzeel and colleagues evaluate whether women with left bundle branch block benefit from cardiac resynchronization therapy defibrillators at a shorter QRS duration than men. In their Invited Commentary, Merz and Regitz-Zagrosek further explore the case for sex-specific interventions.
Buchhalter and colleagues describe features and outcomes of patients who underwent cardiovascular implantable electronic device deactivation. Also see the Invited Commentary by Matlock and Mandrola.